Fox Chase Cancer Center News

By aligning treatment with patients’ values and goals, Fox Chase Cancer Center clinicians are infusing Goal Concordant Care into routine practice, partnering with their patients to honor what matters most when facing serious illness.

Discoveries from Siddharth Balachandran, PhD, reveal how the same immune pathways that fight viruses can be harnessed to make cancer immunotherapy more effective, highlighting the transformative power of basic science.

Khariton joins Fox Chase during a period of sustained growth and integration of its clinical services and research enterprise across Temple Health, the Lewis Katz School of Medicine and Temple University.

Fox Chase was ranked at or above the 95th percentile for the honor, which highlights how employee and physician engagement strengthen research excellence and patient care.

SpotitEarly, an early cancer detection startup that uses AI and trained canines to identify cancer odor signatures in breath samples, enters a strategic partnership with Fox Chase Cancer Center.

New research from Fox Chase Cancer Center confirms that preoperative radiation therapy does not reduce surgical complexity, reinforcing evidence that most patients benefit from proceeding directly to surgery.

New research from Fox Chase Cancer Center reveals a natural “safety switch” that allows liver cells to pause growth during injury, helping protect against cancer while the liver heals and pointing to potential new treatments for chronic liver disease.

Fox Chase Cancer Center and Omniscope, a leader in advanced molecular profiling technology announced a new research collaboration aimed at identifying novel biomarkers for immune checkpoint inhibitor (ICI) response in non-small cell lung cancer.